Oct 16: Academic Medicine and the Cardiovascular department
What makes Banner Good Samaritan so unique and why should patients travel to 12th and McDowell? We keep talking about our physicians — physicians who are world class, nationally known for training future generations of other physicians and at the forefront of medicine.
Here at Banner Good Samaritan, we have an outstanding group of cardiologists, vascular surgeons and CV surgeons, who are working to develop an institute for cardiovascular medicine.
Let’s read the words of Dr. Ashish Pershad, an Interventional Cardiologist at Banner Good Samaritan, as he describes an example of the academic brand being created at BGSMC — a brand that will elevate our future institute, attracting patients far and wide.
On October 7 and 8, we had physicians from 15 states including well-known academic medical centers like the University of Michigan, University of Pittsburgh and Texas Heart come through Banner Good Sam to learn from our own faculty the latest techniques in managing a condition known as Chronic Total Occlusions (CTOs).
Steve Narang, MD, is the chief executive officer at Banner Good Samaritan Medical Center.
Background on Coronary Artery Disease and Chronic Total Occlusions (CTOs)
Dr. Ashish Pershad, Interventional Cardiologist
Heart disease is responsible for one in every four deaths in the United States and is the leading cause of death for both men and women. Coronary artery disease is the most common type of heart disease, killing more than 385,000 people annually.
Approximately every 34 seconds, one American has a coronary event, and approximately every minute, an American will die of one. Each year, coronary heart disease costs the United States nearly $109 billion in health care services, medications and lost productivity.
Coronary CTOs are commonly encountered complex lesions defined as greater than 99 percent blocked for three months or more, and are responsible for clinically significant decrease in blood flow (TIMI 0-1). They are identified in up to 31 percent of patients referred for coronary angiography.
Patients suffering from CTOs are frequently treated with medication or bypass surgery. Many patients are told that nothing can be done to open their CTO using minimally invasive angioplasty techniques. Traditionally, fewer than five percent of CTOs in the USA have been treated by percutaneous coronary intervention (PCI), also known as angioplasty.
Since implementation of a new Hybrid approach to CTO developed by 13 Interventional cardiologists from across the country, cardiologists are achieving procedural success rates as high as 90-95 percent, with complication rates as low as one to three percent.
We know that heart disease is responsible for one in four deaths in the U.S. and remains the country’s No. 1 killer of both men and women. Less known is the fact that CTOs affect the survival and quality of life of hundreds of thousands of people, and have historically been an untreatable condition for many patients. While some are treated with bypass surgery, 60 percent of patients with CTOs are treated only with prescription drugs and told that nothing can be done for them.
CTO-PCI is complex, but the combination of new technologies and techniques is making it more efficient and successful. Banner Good Samaritan has pioneered CTO PCI and Cavanagh Heart Center is a center of excellence in CTO treatment.
Banner Good Samaritan is one of a handful of hospitals in the country that is a designated center of excellence in CTO angioplasty. Along with hospitals such as Yale, Columbia Presbyterian and Mid America Heart Institute, we are a designated site to train physicians from across the country in this pioneering technique.